VCP
CC icon

Verus Capital Partners’s Chemours CC Stock Holding History

Verus Capital Partners’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$6K Sell
632
-1,235
-66% -$17.8K ﹤0.01% 1123
2019
Q4 		$34K Buy
+1,867
New +$31K 0.01% 715

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Verus Capital Partners's CC Position: Q1 2020 in Review

Verus Capital Partners reduced its Chemours (CC) stake by 66% in Q1 2020, selling an estimated $17.8K and leaving 632 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Verus Capital Partners first reported a position in CC in Q4 2019 and has held it in 2 quarters since. The position peaked at $34K in Q4 2019. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

  • Verus Capital Partners held 632 shares of Chemours worth $6K as of Q1 2020.
  • Verus Capital Partners sold 1,235 Chemours shares in Q1 2020, an estimated $17.8K.
  • Chemours made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1123 holding.
  • Verus Capital Partners first reported a position in Chemours in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Chemours position peaked at $34K in Q4 2019.
  • 416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.